Evidence Hub

Characterizing the Role of Suzetrigine Drug as A Non-Opioid Analgesic for Acute Pain Management

Shraddha Ghadage*, Snehal Kadbhane, Dr. Vijaykumar Kale, Shweta Mahajan, Shweta Dandawthe

Zenodo (CERN European Organization for Nuclear Research), 2025

Abstract

Acute pain is a common clinical condition that greatly affects patient comfort and recovery. Current pain management mainly depends on opioids, which, though effective, have major drawbacks such as dependence, tolerance, and adverse effects. Therefore, there is a strong need for safer and more effective non-opioid alternatives. Suzetrigine is a novel nonopioid analgesic that selectively inhibits the NaV1.8 sodium channel in peripheral nociceptors. This mechanism blocks pain transmission without causing central nervous system side effects or addiction risk related to opioids. The present study aims to characterize the role of Suzetrigine as a non-opioid analgesic for acute pain management, emphasizing its mechanism of action, safety, and therapeutic efficacy. This research can provide important insights for developing safer alternatives to opioids, reducing dependence, and improving pain management outcomes. Although many analgesic agents are available, opioids remain the main treatment for moderate to severe pain. However, their prolonged use leads to several adverse effects such as respiratory depression, sedation, constipation, tolerance, dependence, and risk of addiction. The growing opioid crisis highlights the urgent need for effective non-opioid analgesics that can provide similar pain relief without these limitations. Suzetrigine, a new investigational compound, shows promise in this field. Its mechanism of action does not involve opioid receptors but targets specific…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free